“L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A: A Case Report” (2023) Journal of Renal and Hepatic Disorders, 7(1), pp. 28–33. doi:10.15586/jrenhep.v7i1.154.